Portfolio | Mayo Clinic Business Development

Innovation in action

Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, start-up companies, business ventures and equity investments.

Below is a small sampling.

Impact stories

Mayo Score for Ulcerative Colitis

Tool uncovering new treatment options

Best Next Drug Migraine Algorithm

Using AI to make migraine expertise more accessible.

AI-assisted heart failure screening

New FDA-approved echocardiogram model used to detect disease.

Microvessel cancer diagnostic

Using high-definition ultrasound imaging to accurately diagnose cancer.

Platform therapy PMM2-CDG

Discovery leads to life-changing treatment for young girl with ultra-rare disease.

Stem cell therapy

For perianal fistulas in patients with Crohn’s disease.

Collaborating for cures

Taking research discoveries from bench to bedside.

Oncolytic virus therapies

Sodium-Iodide Symporter reporter gene imaging system.

Phage therapy treatment

Using viruses to target and kill specific bacteria.

Evolving vaccine efforts

Single-cycle adenovirus vaccine platform.

Cancer screening revolution

FDA-approved noninvasive colorectal screening.

Remote ECG patient monitoring

FDA-approved remote heart monitoring device.

Magnetic Resonance Elastography

Cancer screening revolution

FDA-approved noninvasive colorectal screening.

Imaging tool for diagnosing liver fibrosis.